Prevention of laboratory-acquired brucellosis: Significant side effects of prophylaxis [3]

Clinical Infectious Diseases

Volumn 42, Issue 3, 2006, Pages 433-434

  Maley, Michael W ^a,b   Kociuba, Katherine ^a   Chan, Raymond C ^a  

^a SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

^b NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; RIFAMPICIN;

ADULT; ANOREXIA; ANTIBIOTIC PROPHYLAXIS; ANXIETY DISORDER; BLOOD CULTURE; BRUCELLA MELITENSIS; BRUCELLOSIS; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL FEATURE; DEPRESSION; DIAGNOSTIC IMAGING; DRUG EFFECT; DRUG USE; ECHOCARDIOGRAPHY; FACE EDEMA; FEVER; FOLLOW UP; HEPATITIS; HUMAN; INFECTION PREVENTION; INFECTION RISK; LETTER; NAUSEA; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL SAFETY; PRIORITY JOURNAL; SYMPTOM; SYSTOLIC HEART MURMUR; TRAVEL; VOMITING;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BRUCELLA MELITENSIS; BRUCELLOSIS; FEMALE; HUMANS; LABORATORY PERSONNEL; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; RISK FACTORS;

EID: 31044437052     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/499112     Document Type: Letter

References (1)

1. Robichaud S, Libman M, Behr M, Rubin E. Prevention of laboratory-acquired brucellosis. Clin Infect Dis 2004; 38:e119-22.